Contrasting Jushi (OTCMKTS:JUSHF) & Electromed (NYSE:ELMD)

Electromed (NYSE:ELMD – Get Free Report) and Jushi (OTCMKTS:JUSHF – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability.

Earnings and Valuation

This table compares Electromed and Jushi”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Electromed $75.57 million 2.60 $5.15 million $1.38 17.17
Jushi $262.91 million 0.32 -$68.59 million ($0.28) -1.48

Electromed has higher earnings, but lower revenue than Jushi. Jushi is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Electromed and Jushi’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Electromed 11.34% 15.71% 13.37%
Jushi -19.98% N/A -12.91%

Insider and Institutional Ownership

40.8% of Electromed shares are owned by institutional investors. Comparatively, 21.7% of Jushi shares are owned by institutional investors. 11.0% of Electromed shares are owned by company insiders. Comparatively, 23.1% of Jushi shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations for Electromed and Jushi, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed 0 1 3 0 2.75
Jushi 0 0 1 0 3.00

Electromed currently has a consensus price target of $43.75, indicating a potential upside of 84.65%. Given Electromed’s higher probable upside, analysts clearly believe Electromed is more favorable than Jushi.

Risk and Volatility

Electromed has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Jushi has a beta of -0.61, indicating that its stock price is 161% less volatile than the S&P 500.

Summary

Electromed beats Jushi on 11 of the 14 factors compared between the two stocks.

About Electromed

(Get Free Report)

Electromed, Inc. develops, manufactures and markets airway clearance products for people who have difficulty clearing mucus from their lungs. Its products use high-frequency chest wall oscillation, a therapy that applies gentle vibrations to the chest to help loosen and move airway secretions. The company’s main product line is the SmartVest Airway Clearance System, which includes wearable vests and related equipment. These systems are used in managing conditions associated with impaired mucus clearance, including bronchiectasis, cystic fibrosis and certain neuromuscular disorders.

About Jushi

(Get Free Report)

Jushi Holdings Inc. is a U.S. cannabis company focused on cultivating, processing and selling cannabis products. Its business includes cultivation and manufacturing facilities as well as retail dispensaries serving medical and adult-use customers in markets where cannabis sales are permitted. The company’s product portfolio has included flower, concentrates, vapes and other cannabis products sold under brands such as The Bank, The Lab and Sèchè. Its retail operations have included the Beyond Hello dispensary brand.

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.